Patrick Sauvageau Elected to Optonique’s Board of Directors
At the third annual general meeting of Optonique, which was held virtually on June 11, Zilia’s CEO, Dr. Patrick Sauvageau, has been elected to the board of directors.
Patrick joins 8 other directors who, in these uncertain times, will aim to promote the Quebec optics‑photonics industry in Canada and abroad.
Optonique, Quebec’s pole of excellence in optics-photonics, is a non-profit industry hub whose mission is to contribute to the advancement of the optics‑photonics industry in Quebec.
To learn more about Optonique visit: https://optonique.ca/en/
Written by the Zilia team on June 18, 2020
Further Reading
Zilia Launches Clinical Study to Investigate Ocular Oximetry as a New Glaucoma Biomarker
Quebec City, July 2, 2025 – Zilia is launching a new clinical trial in collaboration with Dr. Paul...
Zilia Launches Ocular Oximetry Study for Ischemic Optic Neuropathy and Retinal Vasculitis
Quebec City, June 26, 2025 – Zilia will investigate how measuring oxygen levels in the eye could transform...
Health Canada Approves Zilia Ocular
Quebec City, 19 June 2025 - Zilia, a Canadian health technology company, is proud to announce that its...